National Health Investors Inc. (NYSE:NHI) declared a quarterly dividend on Friday, August 5th. Stockholders of record on Friday, September 30th will be paid a dividend of 0.90 per share by the real estate investment trust on Thursday, November 10th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.46%. The ex-dividend date of this dividend is Wednesday, September 28th.

National Health Investors (NYSE:NHI) opened at 80.75 on Friday. The company has a market capitalization of $3.16 billion, a price-to-earnings ratio of 18.62 and a beta of 0.65. The firm has a 50-day moving average price of $79.58 and a 200-day moving average price of $72.60. National Health Investors has a 12 month low of $54.51 and a 12 month high of $82.53.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.01. National Health Investors had a return on equity of 14.68% and a net margin of 69.69%. The company earned $61.20 million during the quarter, compared to analysts’ expectations of $58.08 million. During the same quarter in the previous year, the company posted $1.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. On average, equities analysts anticipate that National Health Investors will post $4.88 earnings per share for the current fiscal year.

A number of equities analysts have recently issued reports on the company. JMP Securities reissued a “hold” rating on shares of National Health Investors in a report on Saturday, June 4th. Wells Fargo & Co. restated a “hold” rating on shares of National Health Investors in a research report on Sunday, September 4th. Zacks Investment Research upgraded National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Mizuho increased their price target on National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, Stephens assumed coverage on National Health Investors in a research report on Wednesday, September 14th. They set an “overweight” rating and a $84.00 price target on the stock. Six research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $74.14.

In other news, Director Robert A. Mccabe, Jr. sold 800 shares of National Health Investors stock in a transaction that occurred on Tuesday, August 30th. The shares were sold at an average price of $80.29, for a total value of $64,232.00. Following the completion of the sale, the director now directly owns 10,021 shares in the company, valued at $804,586.09. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Kristin Sallee Gaines sold 4,044 shares of National Health Investors stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $73.71, for a total transaction of $298,083.24. Following the completion of the sale, the insider now owns 53,089 shares of the company’s stock, valued at $3,913,190.19. The disclosure for this sale can be found here. Insiders own 5.74% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in National Health Investors by 35.0% in the second quarter. FMR LLC now owns 1,660,500 shares of the real estate investment trust’s stock worth $124,687,000 after buying an additional 430,500 shares during the last quarter. Guggenheim Capital LLC increased its position in shares of National Health Investors by 284.2% in the second quarter. Guggenheim Capital LLC now owns 42,528 shares of the real estate investment trust’s stock valued at $3,192,000 after buying an additional 31,458 shares in the last quarter. Parametric Portfolio Associates LLC increased its position in shares of National Health Investors by 46.2% in the second quarter. Parametric Portfolio Associates LLC now owns 87,809 shares of the real estate investment trust’s stock valued at $6,594,000 after buying an additional 27,743 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of National Health Investors by 27.8% in the second quarter. Alliancebernstein L.P. now owns 89,034 shares of the real estate investment trust’s stock valued at $6,686,000 after buying an additional 19,389 shares in the last quarter. Finally, BlackRock Fund Advisors increased its position in shares of National Health Investors by 2.0% in the second quarter. BlackRock Fund Advisors now owns 986,833 shares of the real estate investment trust’s stock valued at $74,101,000 after buying an additional 19,017 shares in the last quarter. Institutional investors own 67.49% of the company’s stock.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

5 Day Chart for NYSE:NHI

Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.